jump to search | jump to navigation

£50m government fund for access to new cancer drugs

29.07.10 Britain's coalition government plans to boost the sale and use of innovative cancer drugs in the British Health system. Health Secretary Andrew Lansley said that, starting in October, an extra £50 million will be available cancer... more
 

Cerenis SA collects EUR 50m from French government and private investors

28.07.10 Cerenis Therapeutics SA raised EUR40m in a Series C financing round from the French Government and existing investors. The company, based in Toulouse, France, and Ann Arbor, Michigan, said the money will be used to fund Phase 2... more
 

Sanofi in pursuit of Genzyme

27.07.10 Paris-based drug company Sanofi-Aventis appears to be considering spending more than US-$20 billion for Genzyme Corp., the Wall Street Journal reported citing informed circles. This would be the biggest biotech acquisition after... more
 

Novagali's IPO raises EUR22m

23.07.10 Novagali Pharma, a French pharmaceutical company specialized in ophthalmology, has raised EUR22m in an IPO on Euronext Paris and a private placement to institutional investors. The company, which his located in the Génopôle... more
 

Actelion obtains option to acquire privately-held Trophos

22.07.10 Allschwil / Marseille - The Swiss biotech company Actelion pays EUR10m to get a first hand on French Trophos SA. The two companies entered a binding agreement whereby Actelion has time till the end of 2011 to decide over an... more
 

 

More news from 'Western Europe':   BeNeLux   France   Ireland   UK


Metanavigation